Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share (AUTL)

133 filings reported holding AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share as of Q2 2024.
Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share (AUTL) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 178M shares of 265M outstanding shares and own 67.19% of the company stock.
Largest 10 shareholders include Syncona Portfolio Ltd (21.3M shares), Blackstone Inc. (20.5M shares), WELLINGTON MANAGEMENT GROUP LLP (17.9M shares), Deep Track Capital, LP (15.3M shares), Avoro Capital Advisors LLC (12.3M shares), FMR LLC (12.3M shares), TFG Asset Management GP Ltd (8M shares), ARMISTICE CAPITAL, LLC (6.25M shares), Frazier Life Sciences Management, L.P. (4.62M shares), and BlackRock Inc. (4.44M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.